Nicholson Nur 4
4 · Apellis Pharmaceuticals, Inc. · Filed Mar 14, 2024
Insider Transaction Report
Form 4
Nicholson Nur
Chief Technical Officer
Transactions
- Sale
Common Stock
2024-03-13$57.31/sh−7,768$445,161→ 59,739 total - Sale
Common Stock
2024-03-13$58.13/sh−3,452$200,677→ 56,287 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $56.91 - $57.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $57.92 - $58.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.